Table 5.
Patient clinical and demographic characteristics in patient affected by HIV
| HIV infection | 1§ | 2° | 3 |
| Gender | M§ | M° | M |
| Age [years] | 63§ | 57° | 37 |
| HIV Ab | Positive§ | Positive° | Positive |
| HIV RNA | Negative§ | Not detectable° | Not detectable |
| CD4+ [cells/μl] | 400§ | CD4+: 725 (31%) cell/μl° | CD4+: 820 (36%) cell/μl |
| HAART therapy | Yes§ | Yes° | Yes |
| HIV follow-up | No worsening§ | No worsening° | No worsening |
| Duration of adalimumab therapy [weeks] | 96§ | 24° | 12 |
| PASI response | PASI 100§ | PASI 75° | 60% PASI improvement at 12 week |
§
Co-infection TB/HIV
°
Co-infection HIV/HCV.